Roche takes Cipla back to court
29 September 2008
Peter Ollier, Hong Kong
Swiss drugs maker F Hoffman-La Roche has sued Cipla in the Bombay High Court claiming that the Indian generic company has infringed its patent and trade mark for the medicine Valcyte
Valcyte is the name Roche uses to market valganciclovir, a medicine that prevents infections in people who suffer from HIV/AIDS and patients who have undergone organ transplants.
The Chennai patent office granted a patent for Valganciclovir in 2007 without hearing a pre-grant opposition filed by non-profit organization the Lawyers Collective.
Ranbaxy launched a post-grant opposition to the patent grant on February 12 2008 and in June the Delhi Network of Positive People, an organisation representing the needs of people living with HIV/AIDS, also filed an opposition.
Leena...
Only subscribers have complete access to Managing IP Magazine,
log in or
subscribe now.
Alternatively take a
free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial